These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Proxy Statement Pursuant to Section 14(a) of the
|
|||
|
Securities Exchange Act of 1934 (Amendment No.
|
)
|
||
|
|
1)
|
Title of each class of securities to which transaction applies:
|
|
|
|
|
|
|
2)
|
Aggregate number of securities to which transaction applies:
|
|
|
|
|
|
|
3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
|
|
|
|
4)
|
Proposed maximum aggregate value of transaction:
|
|
|
|
|
|
|
5)
|
Total fee paid:
|
|
|
|
|
|
|
1)
|
Amount Previously Paid:
|
|
|
|
|
|
|
2)
|
Form, Schedule or Registration Statement No.:
|
|
|
|
|
|
|
3)
|
Filing Party:
|
|
|
|
|
|
|
4)
|
Date Filed:
|
|
|
|
|
|
•
|
Proposal No. 1—Election of eight directors
|
|
•
|
Proposal No. 2—Ratification of the appointment of PricewaterhouseCoopers LLP as independent auditors for the fiscal year ending June 28, 2020
|
|
•
|
Proposal No. 3—Advisory (nonbinding) vote to approve executive compensation
|
|
|
||
|
1
|
||
|
3
|
||
|
4
|
||
|
|
4
|
|
|
|
4
|
|
|
|
4
|
|
|
|
4
|
|
|
|
4
|
|
|
|
5
|
|
|
|
5
|
|
|
6
|
||
|
|
6
|
|
|
|
13
|
|
|
|
13
|
|
|
|
13
|
|
|
|
14
|
|
|
|
15
|
|
|
|
15
|
|
|
|
16
|
|
|
|
17
|
|
|
|
17
|
|
|
|
19
|
|
|
|
19
|
|
|
|
19
|
|
|
20
|
||
|
|
20
|
|
|
22
|
||
|
|
22
|
|
|
|
40
|
|
|
|
41
|
|
|
|
42
|
|
|
|
43
|
|
|
|
44
|
|
|
|
45
|
|
|
|
53
|
|
|
|
54
|
|
|
55
|
||
|
|
55
|
|
|
|
54
|
|
|
|
54
|
|
|
57
|
||
|
|
57
|
|
|
|
58
|
|
|
59
|
||
|
60
|
||
|
|
60
|
|
|
|
60
|
|
|
|
60
|
|
|
|
60
|
|
|
|
61
|
|
|
|
61
|
|
|
|
61
|
|
|
|
61
|
|
|
Annual Meeting of Shareholders
|
•
|
Place:
Cree, Inc. offices in Customer Center 6, 4408 Silicon Drive, Durham, North Carolina 27703
|
|
|
•
|
Date and time:
Monday, October 28, 2019, at 12:00 p.m.
|
|
|
•
|
Record Date:
August 30, 2019
|
|
|
•
|
Approximate Date of Availability of Proxy Materials
: September 16, 2019
|
|
|
•
|
Voting:
Shareholders as of the record date are entitled to vote. Each share of common stock is entitled to vote for each director nominee and to one vote for each of the other proposals to be voted on.
|
|
|
|
|
|
Voting matters and Board recommendations
|
•
|
Election of eight directors
(FOR THE NOMINEES)
|
|
|
•
|
Ratification of the appointment of PricewaterhouseCoopers LLP as our independent auditors for the fiscal year ending June 28, 2020
(FOR)
|
|
|
•
|
Advisory (nonbinding) vote to approve executive compensation
(FOR)
|
|
|
|
|
|
Board nominees
|
•
|
John C. Hodge.
Founding Partner of Rubicon Technology Partners. Cree Director since 2018.
|
|
|
•
|
Clyde R. Hosein.
Executive Vice President and Chief Financial Officer of Automation Anywhere, Inc. Cree Director since 2005.
|
|
|
•
|
Darren R. Jackson.
Former Board Member and Chief Executive Officer of Advance Auto Parts, Inc. Cree Director since 2016.
|
|
|
•
|
Duy-Loan T. Le.
President of DLE Management Consulting LLC. Cree Director since 2018.
|
|
|
•
|
Gregg A. Lowe.
Cree, Inc. President and Chief Executive Officer. Cree Director since 2017.
|
|
|
•
|
John B. Replogle.
Founding Partner of One Better Ventures, LLC. Cree Director since 2014.
|
|
|
•
|
Thomas H. Werner.
Chairman and Chief Executive Officer of SunPower Corporation. Cree Director since 2006.
|
|
|
•
|
Anne C. Whitaker.
Chief Executive Officer of Dance Biopharm Holdings, Inc. Cree Director since 2013.
|
|
Executive officers at end of fiscal year
|
•
|
Gregg A. Lowe
, President and Chief Executive Officer
|
|
|
•
|
Neill P. Reynolds
, Executive Vice President and Chief Financial Officer
|
|
Independent auditors
|
|
Although not required, we ask shareholders to ratify the selection of PricewaterhouseCoopers LLP as our independent auditors for our fiscal year ending June 28, 2020. Our Board of Directors recommends a FOR vote.
|
|
|
|
|
|
Advisory (nonbinding) vote to approve executive compensation
|
|
Annually, our shareholders consider and vote on the compensation of our named executive officers on an advisory (nonbinding) basis. Our Board of Directors recommends a FOR vote.
|
|
•
|
Voting by Internet.
You can vote over the Internet by following the directions on your Notice to access the website address at
www.proxyvote.com
. The deadline for voting over the Internet is Sunday, October 27, 2019 at 11:59 p.m. Eastern time.
|
|
•
|
Voting by Telephone.
You can vote by calling the toll-free telephone number at 1-800-690-6903. The deadline for voting by telephone is Sunday, October 27, 2019 at 11:59 p.m. Eastern time.
|
|
•
|
Voting by Mail.
If you requested printed proxy materials, you can vote by completing and returning your signed proxy card. To vote using your proxy card, please mark, date and sign the card and return it by mail in the accompanying postage-paid envelope. You should mail your signed proxy card sufficiently in advance for it to be received by Sunday, October 27, 2019.
|
|
•
|
Voting in Person.
You can vote in person at the meeting if you are the record owner of the shares to be voted. You can also vote in person at the meeting if you present a properly signed proxy that authorizes you to vote shares on behalf of the record owner. If a broker, bank, custodian or other nominee holds your shares, to vote in person at the meeting you must present a letter or other proxy appointment, signed on behalf of the broker or nominee, granting you authority to vote the shares.
|
|
•
|
Proposal 1 (Election of Directors)
. Directors will be elected by a plurality of the votes cast. The eight nominees who receive the most votes will be elected to fill the available positions. Shareholders do not have the right to vote cumulatively in electing directors. Withholding authority in your proxy to vote for a nominee will result in the nominee receiving fewer votes.
|
|
•
|
Proposal 2 (Ratification of Appointment of Auditors)
. The proposed ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditors for fiscal 2020 will be approved if the votes cast for approval exceed the votes cast against approval. Although shareholder ratification of the appointment is not required by law or the Company’s Bylaws, the Audit Committee has determined that, as a matter of corporate governance, the selection of independent auditors should be submitted to the shareholders for ratification. If the appointment of PricewaterhouseCoopers LLP is not ratified by a majority of the votes cast at the 2019 Annual Meeting, the Audit Committee will consider the appointment of other independent auditors for subsequent fiscal years. Even if the appointment is ratified, the Audit Committee may change the appointment at any time during the year if it determines that the change would be in the Company’s best interest and the best interests of the shareholders.
|
|
•
|
Proposal 3 (Advisory (Nonbinding) Vote to Approve Executive Compensation)
. With respect to the advisory (nonbinding) vote to approve executive compensation, the executive compensation will be approved if the votes cast for approval exceed the votes cast against approval. Because your vote to approve executive compensation is advisory, it will not be binding upon the Board of Directors, it will not overrule any decision by the Board, and it will not create or imply any additional fiduciary duties on the Board or any member of the Board. The Compensation Committee will, however, take into account the outcome of the vote when considering future executive compensation arrangements.
|
|
Name
|
Age
|
Principal Occupation and Background
|
Director
Since
|
|
John C. Hodge
|
52
|
Mr. Hodge has been a member of the Board of Directors since October 2018. He is a founding partner of private-equity firm Rubicon Technology Partners, which he joined in 2012. Prior to that, Mr. Hodge was a Senior Advisor and Senior Managing Director with Blackstone Group, a private equity firm, from 2006 to 2011. From 1998 to February 2006, Mr. Hodge was Senior Advisor, Managing Director and Global Head of Corporate Finance of the Technology Group of Credit Suisse First Boston. He also previously held positions at Morgan Stanley and Robertson Stephens. Mr. Hodge has spent more than 25 years as an investor in and advisor to the global semiconductor and technology industry.
Mr. Hodge’s qualifications to serve as a director include his years of experience in private equity, corporate finance, and merger and acquisition transactions and his extensive experience as a director of semiconductor companies, including Silicon Image, Inc. from 2007 to 2014 and Freescale Semiconductor, Ltd. from 2008 to 2011. He brings to the Company’s Board of Directors his financial expertise and his work as a private equity investor analyzing and focusing on creating long-term value through operational improvements utilizing a repeatable process driven approach.
|
2018
|
|
Clyde R. Hosein
|
60
|
Mr. Hosein has been a member of the Board of Directors since December 2005. Since December 2017, he has served as Chief Financial Officer of Automation Anywhere, Inc., an enterprise software provider of robotic process automation. From August 2013 to May 2017, he served as Executive Vice President and Chief Financial Officer of RingCentral, Inc., a publicly traded provider of software-as-a-service cloud-based business communications solutions. Prior to this, Mr. Hosein served from June 2008 to October 2012 as Chief Financial Officer of Marvell Technology Group Ltd., a publicly traded semiconductor provider of high-performance analog, mixed-signal, digital signal processing and embedded microprocessor integrated circuits, and he also served as its Interim Chief Operating Officer and Secretary from October 2008 to March 2010. From 2003 to 2008, he served as Vice President and Chief Financial Officer of Integrated Device Technology, Inc., a provider of mixed-signal semiconductor solutions. From 2001 to 2003, he served as Senior Vice President, Finance and Administration and Chief Financial Officer of Advanced Interconnect Technologies, a semiconductor assembly and test company. He has also held other senior level financial positions, including the role of Chief Financial Officer at Candescent Technologies, a developer of flat panel display technology. Early in his career he spent 14 years in financial and engineering roles at IBM Corporation.
Mr. Hosein’s qualifications to serve as a director include his years of experience as an executive officer in publicly traded companies in the semiconductor industry, including his roles in operational management, his substantial experience as a chief financial officer responsible for the finance and accounting functions of publicly traded companies, his qualifications as an audit committee financial expert, and his technical background and significant experience in technology-based companies generally.
|
2005
|
|
Name
|
Age
|
Principal Occupation and Background
|
Director
Since
|
|
Darren R. Jackson
|
54
|
Mr. Jackson joined the Board of Directors in May 2016, and has served as Chairman of the Board of Cree since October 2018. From July 2004 to January 2016, he served on the Board of Directors of Advance Auto Parts, Inc., and served as its Chief Executive Officer from January 2008 to January 2016. Mr. Jackson also served as President of Advance Auto Parts from January 2008 to January 2009 and from January 2012 to April 2013. Prior to this, Mr. Jackson served in various executive positions with Best Buy Co., Inc., a specialty retailer of consumer electronics, office products, appliances and software, ultimately serving from July 2007 to December 2007 as Executive Vice President of Customer Operating Groups. Mr. Jackson joined Best Buy in 2000 and was appointed as its Executive Vice President-Finance and Chief Financial Officer in February of 2001. Prior to 2000, he served as Vice President and Chief Financial Officer of Nordstrom, Inc., Full-line Stores, a fashion specialty retailer, and held various senior positions, including Chief Financial Officer of Carson Pirie Scott & Company, a regional department store company. Mr. Jackson has also served as a director of Fastenal Company (NASDAQ: FAST), which sells industrial and construction supplies, since July 2012.
Mr. Jackson’s qualifications to serve as a director include his years as a Chief Executive Officer, President and Chief Financial Officer of publicly traded companies in the retail and distribution industries, including his operational, logistical and executive management, financial and accounting acumen and experience.
|
2016
|
|
Duy-Loan T. Le
|
57
|
Ms. Le has served on the Board of Directors since October 2018. She retired from Texas Instruments Inc. (NASDAQ: TXN) in February 2015, most recently holding the title of Senior Fellow since 2002. During her 33 year career at Texas Instruments, Ms. Le held various leadership positions, including Advanced Technology Ramp Manager for the Embedded Processing Division and worldwide project manager for the Memory Division. Since 2016, she has been president and sole partner of DLE Management Consulting LLC, a management consulting firm. Ms. Le has 33 years of experience in semiconductors, specifically in chip design, silicon manufacturing technology development, and advanced technology manufacturing from concept to high volume production, and 33 years of global business experience, including managing global R&D centers, joint ventures, foundries, and OSAT (Outsourced Semiconductor Assembly and Test) partnerships in Asia and Europe. Ms. Le is currently a member of the board of directors of Ballard Power Systems (NASDAQ: BLDP) and National Instruments Corp. (NASDAQ: NATI).
Ms. Le’s qualifications to serve as a director include her extensive experience in various aspects of semiconductor design and manufacture, including operations, research and development, product launch, customer interfacing, foundry partnership, and supply chain management while at Texas Instruments. She also has 17 years of experience serving on public company boards of directors.
|
2018
|
|
Name
|
Age
|
Principal Occupation and Background
|
Director
Since
|
|
Gregg A. Lowe
|
57
|
Mr. Lowe has served as the Company’s President, Chief Executive Officer and as a member of the Board of Directors since September 2017. From June 2012 to December 2015, he served as president and CEO of Freescale Semiconductor, Ltd., a $5 billion company with 17,000 employees and products serving automotive, industrial, consumer and communications markets. Prior to that, he had a long career spanning 28 years at Texas Instruments, most recently serving as senior vice president and leader of the analog business. In addition to his experience with semiconductor companies, Mr. Lowe also holds board positions with Silicon Labs in Austin, Texas (NASDAQ: SLAB) and The Rock and Roll Hall of Fame in Cleveland, Ohio, where he co-chairs the education committee for the board.
Mr. Lowe brings to the Board extensive leadership and deep industry experience from his long career serving publicly-traded companies in the semiconductor industry. Further, Mr. Lowe’s leadership position as the Chief Executive Officer of the Company equips him with a unique perspective to inform Board deliberations on the vision for the company moving forward in addition to crucial insights on the general management and operations of the Company.
|
2017
|
|
John B. Replogle
|
53
|
Mr. Replogle joined the Board of Directors in January 2014. Since October 2017, he has served as a Founding Partner of One Better Ventures, LLC, a venture capital firm focused on consumer brands that have a positive impact. From March 2011 to October 2017, he served as Chief Executive Officer and President of Seventh Generation, Inc., a manufacturer and distributor of sustainable household products. From 2006 to 2011, Mr. Replogle served as President and Chief Executive Officer of Burt's Bees, Inc., and from 2003 to 2006, he served as General Manager of Unilever's Skin Care division. Previously, he worked for Diageo, Plc for seven years in a number of different capacities, including as President of Guinness Bass Import Company and Managing Director of Guinness Great Britain. He started his career with the Boston Consulting Group. Mr. Replogle also served as a director of Sealy Corporation, a publicly traded mattress manufacturer, from 2010 to 2013, until its sale to Tempur-Pedic International Inc.
Mr. Replogle’s qualifications to serve as a director include significant senior executive leadership experience, including eleven years of experience as chief executive officer at two companies, as well as deep experience in marketing, branding and distribution of consumer goods. This experience provides him valuable perspective in his role as a director and member of our Audit Committee.
|
2014
|
|
Name
|
Age
|
Principal Occupation and Background
|
Director
Since
|
|
Thomas H. Werner
|
59
|
Mr. Werner has been a member of the Board of Directors since March 2006. He has served as Chief Executive Officer for SunPower Corporation, a publicly traded manufacturer of high-efficiency solar cells and solar panels, since June 2003, and is also Chairman of its Board of Directors. Prior to SunPower, he served as Chief Executive Officer of Silicon Light Machines Corporation, an optical solutions subsidiary of Cypress Semiconductor Corporation, from July 2001 to June 2003. Earlier, Mr. Werner was Vice President and General Manager of the Business Connectivity Group of 3Com Corporation, a network solutions company.
Mr. Werner’s qualifications to serve as a director include significant executive leadership and operational management experience gained at businesses in the technology sector, and the semiconductor industry in particular, including his experience as a chief executive officer of a publicly traded “green technology” company for the past sixteen years.
|
2006
|
|
Name
|
Age
|
Principal Occupation and Background
|
Director
Since
|
|
Anne C. Whitaker
|
52
|
Ms. Whitaker joined the Board of Directors in December 2013. Since October 2018, she has served as the Chief Executive Officer of Dance Biopharm Holdings, Inc., a clinical stage pharmaceutical and medical device company. Ms. Whitaker started her healthcare career in 1991 as a sales representative with The Upjohn Company, now Pfizer, Inc. (NYSE: PFE). She subsequently transitioned to GlaxoSmithKline PLC (NYSE: GSK) in 1992 where she rose in the leadership ranks to become a member of the global management team as the Global Head of the Leadership and Organization Development Centre of Excellence and ultimately served as the Senior Vice President and Business Unit Head for the Cardiovascular, Metabolic, and Urology franchises from September 2009 to September 2011. Ms. Whitaker joined Sanofi SA (Euronext Paris: SAN-FR) in 2011 where she served through August 2014 as the President of the North America Region and CEO of Sanofi US, LLC, where she led more than 5,000 employees to deliver revenues exceeding $16 billion annually. Ms. Whitaker served as the CEO and President of Synta Pharmaceuticals, Inc. (NASDAQ: SNTA) an oncology focused late stage pharmaceutical development company, which is now Madrigal Pharmaceuticals (NASDAQ: MDGL), from September 2014 to April 2015. She joined Bausch Healthcare Companies (NYSE: BHC) in May 2015 and served through January 2017 as Executive Vice President and Company Group Chairman for the global branded pharmaceutical segment where she notably led the successful integration of two multi-billion dollar businesses, Salix Pharmaceuticals and Dendreon. In 2017, Ms. Whitaker transitioned to the early stage biotech sector and helped build Novoclem Therapeutics, Inc., a subsidiary of KNOW Bio, LLC, focused on developing therapies to treat people living with severe, chronic respiratory diseases. Prior to joining Dance Biopharm Holdings, Inc., starting in April 2018, Ms. Whitaker served as Managing Partner for Anne Whitaker Group, LLC, a consultant and professional service firm focused primarily on advising biotech and specialty pharmaceutical companies with commercial and product development strategy.
Ms. Whitaker previously served on the board of publicly traded Synta Pharmaceuticals, Inc. (NASDAQ: SNTA), now Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL). Ms. Whitaker is currently an independent director on the board of two additional publicly traded companies, Mallinckrodt, Plc (NYSE: MKN), a specialty pharmaceutical company, and Vectura Group, Plc (London Exchange: VEC-GB), a pharmaceutical and medical device company. She was appointed in 2018 by the Governor of Alabama to serve as a Trustee for the University of North Alabama.
Ms. Whitaker brings to the Board her experience as a CEO of a publicly traded company along with more than a decade of senior executive commercial and human resource experience at some of the most respected publicly traded global pharmaceutical companies in the world. Her experience in the life science industry growing and managing complex multi-division businesses, along with her insights on product research and development, intellectual property creation and protection, and key commercial functions including market access, customer relationship management, sales and marketing, provide her with a unique perspective in her role as a director and member of our Compensation Committee and Nomination and Governance Committee.
|
2013
|
|
•
|
In the absence of the Chairman, the Lead Independent Director serves as acting Chairman presiding over meetings of the Board of Directors and shareholders;
|
|
•
|
The Lead Independent Director convenes and presides over meetings of the independent directors and communicates the results of these sessions where appropriate to the Chairman, other management or the Board;
|
|
•
|
In general, the Lead Independent Director serves as principal liaison between the independent directors and the Chairman and between the independent directors and other management; and
|
|
•
|
The Lead Independent Director reviews agendas for Board of Directors meetings in advance with the Chairman.
|
|
•
|
restricted stock unit awards and performance stock unit awards under our 2013 Long-Term Incentive Compensation Plan, or the LTIP;
|
|
•
|
performance unit awards payable to our CEO and to our Executive Vice Presidents under the LTIP which provide for cash payments based upon achieving annual corporate financial goals;
|
|
•
|
awards under our cash incentive bonus plan, in which most of our senior managers (other than our currently employed named executive officers) participate and may receive payments based upon achieving annual corporate financial goals; and
|
|
•
|
sales commission incentive programs for our sales personnel.
|
|
Name and Address (1)
|
Common Stock
Beneficially Owned
|
Percentage of
Outstanding Shares
|
|
|
BlackRock, Inc. (2)
55 East 52
nd
Street
New York, NY 10055
|
13,106,544
|
|
12.8%
|
|
ClearBridge Investments, LLC (3)
620 8
th
Avenue
New York, NY 10018
|
10,200,361
|
|
9.9%
|
|
PRIMECAP Management Company (4)
177 E. Colorado Blvd., 11
th
Floor
Pasadena, CA 91105
|
8,465,189
|
|
8.2%
|
|
Artisan Partners Asset Management Inc. (5)
875 E. Wisconsin Ave., Suite 800
Milwaukee, WI 53202
|
8,165,479
|
|
8.0%
|
|
Capital Research Global Investors (6)
333 South Hope Street
Los Angeles, CA 90071
|
5,596,532
|
|
5.4%
|
|
Gregg A. Lowe (7)
|
93,343
|
|
*
|
|
Neill P. Reynolds
|
8,115
|
|
*
|
|
David T. Emerson (8)
|
125,032
|
|
*
|
|
Michael E. McDevitt (9)
|
69,723
|
|
*
|
|
John B. Replogle (10)
|
83,304
|
|
*
|
|
Thomas H. Werner (11)
|
65,446
|
|
*
|
|
Clyde R. Hosein (12)
|
60,316
|
|
*
|
|
Anne C. Whitaker (13)
|
34,653
|
|
*
|
|
Darren R. Jackson
|
33,833
|
|
*
|
|
Duy-Loan T. Le (14)
|
5,481
|
|
*
|
|
John C. Hodge (15)
|
2,587
|
|
*
|
|
All current directors and executive officers as
a group (9 persons) (16)
|
387,078
|
|
*
|
|
*
|
Less than 1%.
|
|
(1)
|
Unless otherwise noted, all addresses are in care of the Company at 4600 Silicon Drive, Durham, NC 27703.
|
|
(2)
|
As reported by BlackRock, Inc. in a Schedule 13G/A filed with the Securities and Exchange Commission on February 11, 2019, which states that BlackRock, Inc. has sole dispositive power with respect to all of such shares and sole voting power with respect to 12,859,984 shares.
|
|
(3)
|
As reported by ClearBridge Investments, LLC in a Schedule 13G/A filed with the Securities and Exchange Commission on February 14, 2019, which states that Clearbridge Investments, LLC has sole dispositive power with respect to all of such shares and sole voting power with respect to 9,775,777 shares.
|
|
(4)
|
As reported by PRIMECAP Management Company in a Schedule 13G/A filed with the Securities and Exchange Commission on February 8, 2019, which states that PRIMECAP Management Company has sole dispositive power with respect to all of such shares and sole voting power with respect to 4,239,129 shares.
|
|
(5)
|
As reported by Artisan Partners Asset Management Inc. in a Schedule 13G filed with the Securities and Exchange Commission on February 7, 2019, which states that Artisan Partners Asset Management Inc. has sole dispositive power with respect to all of such shares and sole voting power with respect to 7,407,553 shares.
|
|
(6)
|
As reported by Capital Research Global Investors in a Schedule 13G filed with the Securities and Exchange Commission on February 13, 2019, which states that Capital Research Global Investors has sole investment and voting authority with respect to all of such shares.
|
|
(7)
|
Includes 52,214 shares subject to RSUs vesting within sixty days of September 6, 2019.
|
|
(8)
|
Mr. Emerson served as the Company’s Executive Vice President and General Manager–LED Products from September 1, 2017 to December 10, 2018. Includes 18,000 shares subject to options exercisable within sixty days of September 6, 2019.
|
|
(9)
|
Mr. McDevitt served as the Company’s Executive Vice President–Finance and Chief Financial Officer from February 4, 2013 to August 26, 2018.
|
|
(10)
|
Includes 4,000 shares subject to options exercisable within sixty days of September 6, 2019.
|
|
(11)
|
Includes 4,000 shares subject to options exercisable within sixty days of September 6, 2019.
|
|
(12)
|
Includes 4,000 shares subject to options exercisable within sixty days of September 6, 2019.
|
|
(13)
|
Includes 4,000 shares subject to options exercisable within sixty days of September 6, 2019.
|
|
(15)
|
Includes 1,481 shares subject to RSUs vesting within sixty days of September 6, 2019.
|
|
Subject
|
Page
|
|
|
23
|
||
|
|
23
|
|
|
|
23
|
|
|
|
24
|
|
|
|
24
|
|
|
|
24
|
|
|
|
25
|
|
|
26
|
||
|
27
|
||
|
|
27
|
|
|
|
28
|
|
|
|
28
|
|
|
|
28
|
|
|
|
29
|
|
|
|
29
|
|
|
|
29
|
|
|
|
30
|
|
|
|
30
|
|
|
|
30
|
|
|
|
31
|
|
|
32
|
||
|
|
32
|
|
|
|
33
|
|
|
|
33
|
|
|
|
33
|
|
|
|
34
|
|
|
|
35
|
|
|
|
36
|
|
|
|
37
|
|
|
|
37
|
|
|
|
38
|
|
|
|
38
|
|
|
•
|
be linked closely to Cree’s operational, financial and business performance;
|
|
•
|
align the interests of the executives with those of Cree’s shareholders;
|
|
•
|
provide incentives for achieving Cree’s financial and business goals; and
|
|
•
|
provide individual executive officers with the opportunity to earn compensation at levels that are competitive with executives in comparable jobs within Cree’s peer company group.
|
|
•
|
base salary;
|
|
•
|
performance-based cash incentive compensation, which is paid annually under our long-term incentive compensation plan (or LTIP) for our Chief Executive Officer (or CEO) and our other named executive officers; and
|
|
•
|
long-term equity incentive compensation, in the form of restricted stock units (RSUs) and performance stock units (PSUs).
|
|
•
|
Gregg A. Lowe, President and Chief Executive Officer; and
|
|
•
|
Neill P. Reynolds, Executive Vice President and Chief Financial Officer (Mr. Reynolds joined Cree on August 27, 2018 as Executive Vice President and Chief Financial Officer, or CFO).
|
|
•
|
Base salaries
. The Committee approved base salary increases for Messrs. Lowe and Emerson of 3% based on a review of competitive market data, their individual performance during the year and the Company’s financial performance. The Committee established an initial base salary for Mr. Reynolds in connection with his August 2018 hiring based on a review of competitive market data and individual negotiations with Mr. Reynolds. Due to the timing of his hiring, Mr. Reynolds was not given an annual merit increase in base salary for fiscal 2019. Mr. McDevitt was not given a base salary increase for fiscal 2019.
|
|
•
|
Aggressive financial targets for performance-based short-term cash incentive compensation
. The Committee established challenging annual Cree-wide financial targets for the named executive officers (including Messrs. McDevitt and Emerson), for the fiscal 2019 performance-based cash incentive programs. The targeted payout for Messrs. Lowe, Reynolds, Emerson and McDevitt were based solely on Cree-wide revenue and non-GAAP gross margin targets. Cree achieved the Cree-wide threshold non-GAAP gross margin target, and therefore Messrs. Lowe and Reynolds were entitled to receive a payout of annual cash incentive compensation under the LTIP as described in “Results and Actual Payouts for Fiscal 2019” below. As described below, in August 2019, the Committee also approved the award of discretionary cash bonuses to Messrs. Lowe and Reynolds to reflect their contributions to the Company’s achievement of a number of important operational and strategic milestones in fiscal 2019, including the sale of Cree’s Lighting Products business unit; execution of a number of sizable wafer supply agreements; and announcement of the Company’s significant capacity expansion. Mr. McDevitt received the benefits under the McDevitt Separation Agreement in lieu of the annual cash incentive compensation under the LTIP. Mr. Emerson did not receive an annual cash incentive compensation payment for fiscal 2019 because he was not continuously employed as an executive officer through the last day of the performance period.
|
|
•
|
Long-term equity compensation
. For fiscal 2019, Cree granted equity awards to the named executive officers (including Mr. Emerson) in the form of RSUs and PSUs to align the interests of the named executive officers with Cree shareholders and to facilitate named executive officer retention. In addition, as discussed below, Cree reached the performance threshold for vesting of (i) the third performance period tranche of the PSUs granted to Messrs. McDevitt and Emerson in September 2016 under the established annual financial targets for fiscal 2019, and as a result, all outstanding shares under these PSUs vested in September 2019; and (ii) the second performance period tranche of the PSUs granted to Messrs. McDevitt and Emerson in September 2017 under the established annual financial targets for fiscal 2019, and as a result, this tranche of shares for these PSUs vested in September 2019.
|
|
•
|
Proportion of performance-based pay
. Based on the Committee’s pay-for-performance philosophy (as further discussed below), as a direct result of the Committee’s compensation decisions, approximately 91% of Mr. Lowe’s target total direct compensation for fiscal 2019 was comprised of variable performance-based pay in the form of short-term cash incentives and long-term equity awards. Mr. Reynolds’s compensation for fiscal 2019 and beyond was negotiated in connection with his hiring as Chief Financial Officer in August 2018. As a result of such negotiation, 77% of Mr. Reynolds’s target total direct compensation for fiscal 2019 was comprised of these components.
|
|
Compensation Element
|
|
Performance Period
|
|
Description
|
|
Fiscal 2019 Target Value (by element)
|
|
Amount Realized for Fiscal 2019
|
|
% of Target
Realized
|
||||
|
Annual Compensation
|
||||||||||||||
|
Annual Cash Compensation
|
||||||||||||||
|
Base Salary
|
|
Fiscal 2019
|
|
Mr. Lowe currently is positioned at approximately the 50th percentile of the market. A 3% increase to base salary was given during fiscal 2019.
|
|
$
|
845,184
|
|
|
$
|
845,184
|
|
|
100%
|
|
Short-Term Incentive
|
|
Fiscal 2019
|
|
Mr. Lowe’s annual cash based incentive target is 140% of his salary. This is positioned between the 50th and 75th percentile of the market. In addition, based on his contribution to Cree’s overall fiscal 2019 operational and strategic results, the Committee desired to increase Mr. Lowe’s actual payout on short-term incentives and a payment equivalent to 150% of target was approved.
|
|
$
|
1,190,000
|
|
|
$
|
1,785,000
|
|
|
150%
|
|
Total Annual Cash Compensation
|
|
$
|
2,035,184
|
|
|
$
|
2,630,184
|
|
|
129.2%
|
||||
|
Fiscal 2019 Long-Term Incentive Compensation
|
||||||||||||||
|
Performance Stock Units
|
|
PSUs granted in prior years for fiscal 2019 performance (grants for fiscal 2018 and fiscal 2019)
|
|
PSUs comprise 50% of our executives targeted annual equity award. Mr. Lowe's equity awards vest three years after the date of grant. The actual number of shares earned will be based on the Company's Relative Shareholder Return compared to a peer group of companies over the period beginning at date of grant and ending three years after the date of grant. As of the end of fiscal 2019, no vesting measurement period has been concluded with respect to PSUs granted to Mr. Lowe, therefore no value from these awards has been realized.
|
|
—
|
|
|
—
|
|
|
—
|
||
|
Restricted Stock Units
|
|
RSUs granted in prior years scheduled to vest for fiscal 2019 service (grants for fiscal 2018 and 2019)
|
|
RSUs comprise 50% of our executives targeted annual equity award. These time-based awards vest equally over four years. This represents the vesting of the stock awards that were granted in fiscal 2018 and 2019.
|
|
$
|
1,447,894
|
|
|
$
|
1,955,936
|
|
|
135.1%
|
|
Total Long-Term Incentive Compensation
|
|
$
|
1,447,894
|
|
|
$
|
1,955,936
|
|
|
135.1%
|
||||
|
Total Realized Compensation for Fiscal 2019
|
|
$
|
3,483,078
|
|
|
$
|
4,586,120
|
|
|
131.7%
|
||||
|
•
|
evaluated each element of compensation as compared to executives in similar roles in Cree’s Peer Group (as defined below) and the Radford Global Technology survey;
|
|
•
|
assessed the performance of the named executive officers then employed at the time, and considered the scope of responsibility and strategic impact of their respective roles within Cree;
|
|
•
|
emphasized variable and performance-based compensation to motivate executives to achieve Cree’s business objectives and align pay with performance; and
|
|
•
|
utilized equity compensation to create a culture of ownership and focus on long-term growth to ensure that equity compensation would continue to play a significant role in the total pay mix for the executives, in order to ensure their alignment with shareholder interests.
|
|
|
|
|
•
|
We regularly speak with long-term shareholders and appreciate the opportunity to gain further insight and understanding into their views, and speak to portfolio managers at almost all of our top 35-40 shareholders at least annually, which represents approximately 85-90% or more of our outstanding shares;
|
|
•
|
We held an Investor Day in February 2018 at which analysts and portfolio managers were invited to meet with Cree’s senior leadership team to discuss Cree’s plans for fiscal 2018 and beyond, and intend to hold another Investor Day in November 2019 to discuss Cree’s plans for fiscal 2020 and beyond; and
|
|
•
|
We communicate with governance and voting personnel at almost all of our top 10 shareholders at least annually, which typically represents approximately 60-65% of our outstanding shares, to solicit feedback on our compensation programs and practices.
|
|
•
|
Reviewing the current executive compensation levels relative to the market and the Company’s performance and assist with recommendations relating thereto;
|
|
•
|
Updating recommendations for stock awards for both executives and employees as a whole;
|
|
•
|
Reviewing the current Outside Director compensation levels relative to the market and assist with recommendations;
|
|
•
|
Supporting Cree’s preparation of documents to be filed with the Securities and Exchange Commission, such as its proxy statement and annual report, with respect to compensation matters; and
|
|
•
|
Keeping the Committee abreast of developments on executive compensation over the course of the year.
|
|
•
|
semiconductor or semiconductor-related business;
|
|
•
|
semiconductor device companies (as opposed to equipment companies);
|
|
•
|
lighting companies;
|
|
•
|
“clean” technology companies (those who offer products and services to reduce the use of natural resources);
|
|
•
|
comparable revenue, market capitalization, and market capitalization as a multiple of revenue;
|
|
•
|
comparable number of employees;
|
|
•
|
companies against which Cree competes for executive talent;
|
|
•
|
companies that allow for sufficient room to grow without over- or under-extending; and
|
|
•
|
sensitivity to the criteria proxy advisor services (e.g., ISS and Glass Lewis) will apply when determining their “Say on Pay” recommendations.
|
|
•
|
add three companies aligned more closely with Cree’s revenue, market capitalization and intended semiconductor focus over the coming years (Cirrus Logic, Inc; Integrated Device Technology, Inc.; Synaptics Incorporated).
|
|
Acuity Brands, Inc.
|
Integrated Device Technology, Inc.
|
|
AVX Corporation
|
Littelfuse, Inc.
|
|
Belden Inc.
|
Marvell Technology Group Ltd.
|
|
Cirrus Logic, Inc.
|
Methode Electronics, Inc.
|
|
Cypress Semiconductor Corporation
|
Microsemi Corporation
|
|
Diodes Incorporated
|
National Instruments Corporation
|
|
Entegris, Inc.
|
Qorvo, Inc.
|
|
First Solar, Inc.
|
Synaptics Incorporated
|
|
Hexcel Corporation
|
Teradyne, Inc.
|
|
Hubbell Incorporated
|
ViaSat, Inc.
|
|
•
|
Base salary increases, if any, are based on:
|
|
-
|
individual performance, including but not limited to, achievement of financial objectives, strategy development and implementation, and overall leadership capabilities including demonstration of the Cree values;
|
|
-
|
responsibilities for which the executive is accountable; and
|
|
-
|
relative position of the executive’s current salary to the market data for that job.
|
|
•
|
Cash-based performance incentive targets as a percentage of base salary are evaluated and approved based on the:
|
|
-
|
level of impact each of the respective executive officer roles has on financial and strategic results;
|
|
-
|
desired mix of base salary, short-term and long-term incentive compensation; and
|
|
-
|
relative position of the executive’s current cash-based performance incentive targets to the market data and comparable short-term incentive targets as a percent of base salary for that job.
|
|
•
|
Equity guidelines are assessed based on the:
|
|
-
|
level of the executive within the organization and the desire to most closely link jobs with the highest impact on financial results to the returns experienced by Cree’s shareholders;
|
|
-
|
scope of responsibilities for which the executive is accountable; and
|
|
-
|
competitive position of Cree’s target long-term equity incentive compensation as compared to the market data.
|
|
Compensation Element
|
Purpose
|
Practice
|
|
Base salary
|
To compensate the executive fairly and competitively for the responsibility level of the position.
|
Fixed compensation paid throughout the year and reviewed annually by the Committee with consideration to our stated compensation philosophy.
|
|
Performance-based cash incentive compensation
|
To motivate and reward organizational achievement of predetermined annual financial goals.
|
Variable cash based compensation linked directly to the achievement of specified corporate financial goals. The CEO and other named executive officers serving for the full fiscal year are eligible for annual payouts for performance units granted under the LTIP. Mr. McDevitt was eligible for a pro-rated cash incentive payment for fiscal 2019, as was outlined in the McDevitt Separation Agreement. For fiscal 2019, the Committee recognized the Company’s achievement of outstanding performance and desired to increase the amount of the total payout for short-term, performance-based cash incentives by awarding an additional cash bonus to Messrs. Lowe and Reynolds.
|
|
Long-term equity incentive compensation
|
To drive executives’ focus on long-term growth and increased shareholder value and to promote retention.
|
Time-based RSUs and performance-based PSUs delivered for fiscal 2019 through a mix of 50% RSUs and 50% PSUs (with the PSUs also having a 3 year cliff vesting TSR measurement). In addition to a grant of RSUs and PSUs for fiscal 2019, Mr. Reynolds was also awarded a time-based RSU sign-on grant, which vests equally over 4 years. Grants based on an evaluation of market data, corporate financial performance and potential retention risks. Equity levels vary among participants based on position and individual performance. Equity comprises a larger portion of the total direct compensation than the other pay elements.
|
|
Post-termination and severance benefits
|
To provide for certain limited economic security in the event an executive officer is terminated without cause or resigns with good reason.
|
Each named executive officer other than the CEO is covered under the SLT Severance Plan, which provides for severance benefits in the event the executive officer is terminated without cause or resigns for good reason. The SLT Severance Plan is described on page 39 below. Mr. Lowe’s post-termination and severance benefits are established under the Change in Control Agreement, which is described on page 39 below.
|
|
Other benefits
|
To provide competitive benefits promoting employee health and productivity.
|
Other benefits are generally those available to all employees. The only perquisite generally offered to named executive officers is the availability of a voluntary comprehensive physical examination once every calendar year. Mr. Reynolds received certain other benefits in connection with his relocation to North Carolina, including a cash sign on bonus of $1,500,000, which was paid in three equal amounts during the first month of his employment and on his six- and 12-month anniversaries with the Company, and moving and relocation reimbursements.
|
|
Executive Officer
|
|
Fiscal 2018 Salary
|
|
Fiscal 2019 Salary
|
|
Percentage Increase
|
|||||
|
Gregg A. Lowe
|
|
$
|
825,000
|
|
|
|
$
|
850,000
|
|
|
3%
|
|
Neill P. Reynolds
|
|
N/A
|
|
|
|
$
|
455,000
|
|
|
N/A
|
|
|
Michael E. McDevitt
|
|
$
|
455,000
|
|
|
|
$
|
455,000
|
|
|
0%
|
|
David T. Emerson
|
|
$
|
400,000
|
|
|
|
$
|
412,000
|
|
|
3%
|
|
•
|
Mr. Lowe’s annual target cash incentive award for fiscal 2019 remained at 140% of base salary, which put Mr. Lowe’s target TCC at approximately the 75
th
percentile of the market data.
|
|
•
|
Mr. Reynolds’s annual target cash incentive award for fiscal 2019 was set at 80% of base salary, which put Mr. Reynolds target TCC at approximately the 50
th
percentile of the market data.
|
|
•
|
Mr. Emerson’s annual target cash incentive award for fiscal 2019 was set at 80% of base salary, which put his target TCC between the 50
th
and the 75
th
percentile of the market data.
|
|
•
|
Per the McDevitt Separation Agreement, Mr. McDevitt’s annual target cash incentive award for fiscal 2019 remained at 80% of his base salary, to be prorated by the portion of the year for which he served as our CFO.
|
|
Performance Goal
|
|
Minimum
|
|
Target
|
|
Maximum
|
|||
|
Adjusted Company Revenue
|
|
$1.33B
|
|
|
$1.47B
|
|
|
$1.61B
|
|
|
Adjusted Company Non-GAAP gross margin %
|
|
30.3
|
%
|
|
34.0
|
%
|
|
35.0
|
%
|
|
Executive Officer
|
|
Target Award
|
|
Actual Award Earned
|
|
Discretionary Cash Bonus
|
|
Total Amount Awarded
|
|
Total Award as a Percent of Target
|
|
Total Award as a Percent of Salary
|
||||||||
|
Gregg A. Lowe
|
|
$
|
1,190,000
|
|
|
$
|
1,241,051
|
|
|
$
|
543,949
|
|
|
$
|
1,785,000
|
|
|
150%
|
|
210%
|
|
Neill P. Reynolds
|
|
$
|
364,000
|
|
|
$
|
379,616
|
|
|
$
|
75,384
|
|
|
$
|
455,000
|
|
|
125%
|
|
100%
|
|
Michael E. McDevitt
1
|
|
$
|
364,000
|
|
|
$
|
64,463
|
|
|
—
|
|
|
$
|
64,463
|
|
|
18%
|
|
14%
|
|
|
David T. Emerson
|
|
$
|
329,600
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
0%
|
|
0%
|
|||
|
1
|
Pursuant to the McDevitt Separation Agreement, Mr. McDevitt received a bonus payment based upon company financial achievement and his time served as the CFO of the Company.
|
|
Executive Officer
|
|
RSUs
|
|
PSUs
|
||
|
Gregg A. Lowe
|
|
58,737
|
|
|
100,692
|
|
|
Neill P. Reynolds
1
|
|
54,887
|
|
|
12,586
|
|
|
Michael E. McDevitt
2
|
|
—
|
|
|
—
|
|
|
David T. Emerson
|
|
10,488
|
|
|
10,488
|
|
|
1
|
Mr. Reynolds was appointed as CFO in August 2018. His awards were approved by the Committee at the August meeting. His sign-on award of 42,301 RSUs was granted on his date of hire on August 27, 2018.
|
|
2
|
Mr. McDevitt did not receive any annual equity grants from Cree for fiscal 2019 in September 2018 due to his retirement as CFO.
|
|
Relative Total Shareholder Return Ranking over Measurement Period
|
|
Payout % Level
|
|
|
75
th
Percentile or Higher
|
|
150
|
%
|
|
50
th
– 74
th
Percentile
|
|
100
|
%
|
|
25
th
– 49
th
Percentile
|
|
50
|
%
|
|
0 – 24
th
Percentile
|
|
0
|
%
|
|
•
|
the CEO is expected to own shares with a value not less than five times his base salary;
|
|
•
|
each other executive officer is expected to own shares with a value not less than two times the officer’s base salary; and
|
|
•
|
each non-employee member of the Board of Directors is expected to own shares with a value not less than five times the sum of the director’s retainers for service on the Board and on Board Committees.
|
|
Name and Principal Position
|
|
Year
|
|
Salary
($)
|
|
Bonus
($)
|
|
Stock
Awards
($) (1)
|
|
Non-Equity Incentive Plan
Compensation
($)
|
|
All Other Compensation
($) (2)
|
|
Total
($)
|
|||||||||||||
|
(a)
|
|
(b)
|
|
(c)
|
|
(d)
|
|
(e)
|
|
(g)
|
|
(i)
|
|
(j)
|
|||||||||||||
|
Gregg A. Lowe
|
|
2019
|
|
$
|
845,184
|
|
|
$
|
543,949
|
|
(3)
|
$
|
7,670,129
|
|
|
$
|
1,241,051
|
|
|
$
|
148,558
|
|
(4)
|
|
$
|
10,448,871
|
|
|
CEO and President
|
|
2018
|
|
$
|
580,666
|
|
|
—
|
|
|
$
|
11,583,043
|
|
|
$
|
859,904
|
|
|
$
|
399,651
|
|
|
|
$
|
13,423,264
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Neill P. Reynolds
|
|
2019
|
|
$
|
358,750
|
|
|
$
|
1,075,384
|
|
(6)
|
$
|
2,605,504
|
|
|
$
|
379,616
|
|
|
$
|
136,275
|
|
(7)
|
|
$
|
4,555,529
|
|
|
Executive Vice President and CFO (5)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Michael E. McDevitt
|
|
2019
|
|
$
|
245,000
|
|
|
—
|
|
|
—
|
|
|
$
|
64,463
|
|
|
$
|
366,643
|
|
(8)
|
|
$
|
676,106
|
|
||
|
Former Executive Vice President
|
|
2018
|
|
$
|
455,004
|
|
|
—
|
|
|
$
|
1,464,454
|
|
|
$
|
100,000
|
|
|
$
|
9,450
|
|
|
|
$
|
2,028,908
|
|
|
|
and CFO
|
|
2017
|
|
$
|
455,004
|
|
|
—
|
|
|
$
|
1,336,999
|
|
|
—
|
|
|
$
|
8,901
|
|
|
|
$
|
1,800,904
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
David T. Emerson
|
|
2019
|
|
$
|
409,698
|
|
|
—
|
|
|
$
|
1,009,155
|
|
|
—
|
|
|
$
|
11,906
|
|
|
|
$
|
1,430,759
|
|
||
|
Former Executive Vice President–
|
|
2018
|
|
$
|
397,223
|
|
|
—
|
|
|
$
|
1,009,939
|
|
|
$
|
258,880
|
|
|
$
|
7,875
|
|
|
|
$
|
1,673,917
|
|
|
|
LED Products
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
(1)
|
Represents the aggregate grant date fair value of service-based RSUs and PSUs granted during the fiscal years shown calculated in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718, Compensation—Stock Compensation, or ASC Topic 718. The aggregate grant date fair value is the amount we expect to expense in our financial statements over the award’s vesting schedule. See Note 14 to our consolidated financial statements included in our Annual Report on Form 10-K for the year ended June 30, 2019 for assumptions used in the calculations. There can be no assurance that the ASC Topic 718 grant date fair value amounts will ever be realized.
|
|
(2)
|
Amounts listed in column (i) include matching contributions to the 401(k) retirement plan. Except as otherwise described below, no named executive officer received perquisites and personal benefits valued, in the aggregate, at $10,000 or more. Therefore, in accordance with Securities and Exchange Commission disclosure rules, this column does not reflect the value of the perquisites and personal benefits received for fiscal 2017 through 2019 unless otherwise noted or previously disclosed.
|
|
(3)
|
The amount reported includes the portion of Mr. Lowe’s short-term cash incentive awarded by the Compensation Committee as an additional cash bonus in excess of the amount earned under his performance unit award for fiscal 2019.
|
|
(4)
|
The amount reported includes relocation and housing expenses of $139,404 in connection with Mr. Lowe’s hiring and tax gross-ups in connection therewith.
|
|
(5)
|
Mr. Reynolds was appointed as Executive Vice President and Chief Financial Officer on August 27, 2018.
|
|
(6)
|
The amount reported includes (a) in connection with Mr. Reynolds’s appointment as Executive Vice President and CFO, the cash payment of $500,000 Mr. Reynolds received within the first month of his employment and the separate cash payment of $500,000 on his six-month anniversary with the Company, and (b) the portion of Mr. Reynolds’s short-term cash incentive awarded by the Compensation Committee as an additional cash bonus in excess of the amount earned under his performance unit award for fiscal 2019.
|
|
(7)
|
The amount reported includes (a) relocation and housing expenses of $117,936 in connection with Mr. Reynolds’s hiring and tax gross-ups in connection therewith, in each case in accordance with the Company’s relocation guidelines, and (b) reimbursement for attorneys’ fees in the amount of $6,789.
|
|
(8)
|
The amount reported includes $364,000 paid pursuant to the McDevitt Separation Agreement (see “Compensation Discussion and Analysis—Additional Information—Post-Termination Arrangements—Separation, General Release and Consulting Agreement with Mr. McDevitt” above for more information).
|
|
|
|
Grant Date
|
|
Approval Date
|
|
Estimated
Possible Payouts
Under Non-Equity
Incentive Plan
Awards (1)
|
|
Estimated
Possible Payouts
Under Equity
Incentive Plan
Awards (2)
|
|
All Other
Stock
Awards:
Number
of Shares
of Stock
or Units
(#) (3)
|
|
All Other Option
Awards:
Number of Securities Underlying Options
(#)
|
|
Exercise
or Base
Price of Option Awards
($/Sh)
|
|
Grant
Date Fair
Value of
Stock and Option
Awards
($)
|
||||||||||||||||||||||
|
Name
|
|
|
Threshold ($)
|
|
Target
($)
|
|
Maximum ($)
|
|
Threshold (#)
|
|
Target
(#)
|
|
Maximum (#)
|
|
||||||||||||||||||||||||
|
Gregg A.
|
|
|
|
|
|
$
|
595,000
|
|
|
$
|
1,190,000
|
|
|
$
|
2,380,000
|
|
|
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Lowe
|
|
9/1/2018
|
|
8/20/2018
|
|
—
|
|
|
—
|
|
|
—
|
|
|
75,519
|
|
|
100,692
|
|
|
151,038
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
4,844,292
|
|
|||
|
|
|
9/1/2018
|
|
8/20/2018
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
58,737
|
|
|
—
|
|
|
—
|
|
|
$
|
2,825,837
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Neill P.
|
|
|
|
|
|
$
|
182,000
|
|
|
$
|
364,000
|
|
|
$
|
728,000
|
|
|
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Reynolds
|
|
9/1/2018
|
|
8/20/2018
|
|
—
|
|
|
—
|
|
|
—
|
|
|
9,440
|
|
|
12,586
|
|
|
15,733
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
605,512
|
|
|||
|
|
|
9/1/2018
|
|
8/20/2018
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
12,586
|
|
|
—
|
|
|
—
|
|
|
$
|
605,512
|
|
|||
|
|
|
8/27/2018
|
|
8/20/2018
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
42,301
|
|
|
—
|
|
|
—
|
|
|
$
|
1,999,991
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Michael E.
|
|
|
|
|
|
$
|
30,906
|
|
|
$
|
61,811
|
|
|
$
|
123,623
|
|
|
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
McDevitt
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
David T.
|
|
|
|
|
|
$
|
164,800
|
|
|
$
|
329,600
|
|
|
$
|
659,200
|
|
|
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Emerson
|
|
9/1/2017
|
|
8/28/2017
|
|
—
|
|
|
—
|
|
|
—
|
|
|
7,866
|
|
|
10,488
|
|
|
13,110
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
504,578
|
|
|||
|
|
|
9/1/2017
|
|
8/28/2017
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
10,488
|
|
|
—
|
|
|
—
|
|
|
$
|
504,578
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
(1)
|
Non-equity incentive plan awards represent the threshold, target and maximum amounts of cash incentive compensation payable under the performance units granted under the LTIP. For Mr. McDevitt, these amounts have been prorated by the portion of the year for which he served as CFO in accordance with the McDevitt Separation Agreement. The actual amounts earned are disclosed in the “Non-Equity Incentive Plan Compensation” column of the “Summary Compensation Table.” Threshold payment amounts assume only the attainment of the minimum goals and are paid at 50% of the target incentive. Target payment amounts are paid at 100% of the target incentive and assume goal attainment of 100% of the target goals. Maximum payment amounts reflect the payout cap of 200% of the target incentive, which assumes goal attainment of the maximum goals. Annual corporate financial targets for Messrs. Lowe, Reynolds, McDevitt and Emerson for fiscal 2019 were solely based on Cree-wide financial targets. For additional information regarding the LTIP and performance units, see “Compensation Discussion and Analysis” above.
|
|
(2)
|
PSUs are granted at target on the grant date. Actual shares awarded on the third anniversary of the grant date is based on the payout factor that corresponds with the Company’s RTSR percentile rank compared to the TSR Peer Group. Maximum opportunity is 150% of the target if the Company ranks in the top quartile, target is 100% if the Company ranks in the second quartile, threshold is 50% if the Company ranks in the third quartile and no payout if the Company ranks in the fourth (bottom) quartile.
|
|
(3)
|
The RSUs granted to Messrs. Lowe, Reynolds and Emerson vest in four annual installments commencing on the first anniversary of the date of grant, provided the recipient continues service as an employee or as a member of the Board of Directors.
|
|
|
|
Option Awards (1)
|
|
Stock Awards (1)
|
||||||||||||||||||||||||
|
Name
|
|
Number of Securities Underlying Unexercised Options (#)
Exercisable
|
|
Number of Securities Underlying Unexercised Options (#)
Unexercisable
|
|
Option
Exercise
Price
($/Sh)
|
|
Option Expiration
Date (2)
|
|
Number of
Shares or
Units of Stock
That Have
Not
Vested (#)
|
|
Market Value of
Shares or Units
of Stock That
Have Not
Vested
($) (3)
|
|
Equity Incentive
Plan Awards:
Number of
Unearned Shares,
Units or Other
Rights That Have
Not Vested (#)
|
|
Equity Incentive
Plan Awards:
Market or Payout
Value of Unearned
Shares, Units or
Other Rights That
Have Not Vested ($)
|
||||||||||||
|
Gregg A.
|
|
|
|
|
|
|
|
|
|
|
215,377
|
|
(4)
|
|
$
|
12,099,880
|
|
|
|
|
|
|
||||||
|
Lowe
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
309,546
|
|
(5)
|
|
$
|
17,390,294
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Neill P.
|
|
|
|
|
|
|
|
|
|
|
54,887
|
|
(6)
|
|
$
|
3,083,552
|
|
|
|
|
|
|
||||||
|
Reynolds
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,586
|
|
(7)
|
|
$
|
707,081
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Michael E.
|
|
|
|
|
|
|
|
|
|
|
47,488
|
|
(8)
|
|
$
|
2,667,876
|
|
|
|
|
|
|
||||||
|
McDevitt
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31,935
|
|
(9)
|
|
$
|
1,794,108
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
David T.
|
|
9,000
|
|
|
|
|
|
$
|
54.60
|
|
|
9/3/2020
|
|
56,428
|
|
(10)
|
|
$
|
3,170,125
|
|
|
|
|
|
|
|||
|
Emerson
|
|
9,000
|
|
|
|
|
|
$
|
45.13
|
|
|
9/2/2021
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
29,486
|
|
(11)
|
|
$
|
1,656,467
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
Option Awards
|
|
Stock Awards
|
|
||||||||||
|
Name
|
|
Number of
Shares Acquired
on Exercise(#)
|
|
Value
Realized on
Exercise ($)
|
|
Number of
Shares Acquired
on Vesting (#)
|
|
Value
Realized on
Vesting ($)
|
|||||||
|
Gregg A. Lowe
|
|
—
|
|
|
—
|
|
|
52,214
|
|
|
$
|
1,955,936
|
|
(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Neill P. Reynolds
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Michael E. McDevitt
|
|
82,000
|
|
|
$
|
1,691,135
|
|
|
28,265
|
|
|
$
|
1,359,829
|
|
(2)
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
David T. Emerson
|
|
70,000
|
|
|
$
|
1,701,480
|
|
|
16,672
|
|
|
$
|
802,090
|
|
(2)
|
|
|
|
|
|
|
|
8,319
|
|
|
$
|
458,710
|
|
(3)
|
|||
|
|
|
|
|
|
|
|
|
|
|
||||||
|
(1)
|
For RSUs, the value realized on vesting is based on $37.46 per share (the closing price of our common stock as reported by Nasdaq on September 27, 2018).
|
|
(2)
|
For this grant of RSUs, the value realized on vesting is based on $48.11 per share (the closing price of our common stock as reported by Nasdaq on September 1, 2018).
|
|
(3)
|
For this grant of RSUs, the value realized on vesting is based on $55.14 per share (the closing price of our common stock as reported by Nasdaq on June 1, 2019).
|
|
Change in Control Agreement (Mr. Lowe):
|
|
SLT Severance Plan:
|
||
|
•
|
continued payment of Mr. Lowe’s base salary for 24 months;
|
|
•
|
continued payment of the executive’s regular salary for 18 months;
|
|
•
|
a lump sum payment equal to two times his target annual incentive award for the fiscal year in which the termination occurs;
|
|
•
|
a lump sum payment equal to 1.5 times the executive’s target annual incentive award for the year in which the termination occurs;
|
|
•
|
a lump sum payment equal to 24 multiplied by the COBRA premium in effect for the type of medical, dental, and vision coverage then in effect for Mr. Lowe;
|
|
•
|
a lump sum payment equal to 18 multiplied by the COBRA premium in effect for the type of medical, dental, and vision coverage then in effect for the executive;
|
|
•
|
full accelerated vesting with respect to his then outstanding, unvested RSUs and other equity awards that vest solely based on the passage of time, and full accelerated vesting with respect to his then outstanding, unvested PSUs, with all performance objectives deemed to have been satisfied at the greater of (i) the target level (target being a Payout Factor of 1); (ii) the actual performance level (with the date of the Change in Control being treated as the ending date for the measurement period and the effective stock price of the Change in Control being used for the calculation of relative total shareholder return); and
|
|
•
|
accelerated vesting of RSUs and options that are subject to time-based vesting requirements only, so that they become vested by the date employment terminates, and deemed vesting of any unvested PSUs at the greater of (i) the target level and (ii) the actual performance level; and
|
|
•
|
reimbursement by the Company for any loss incurred in the sale of Mr. Lowe’s primary North Carolina residence.
|
|
•
|
outplacement benefits for 12 months.
|
|
Change in Control Agreement (Mr. Lowe):
|
|
SLT Severance Plan:
|
||
|
•
|
continued payment of Mr. Lowe’s base salary for 18 months;
|
|
•
|
continued payment of the executive’s base salary for 12 months;
|
|
•
|
a lump sum payment equal to 1.5 times his target annual incentive award for the fiscal year in which the termination occur;
|
|
•
|
a lump sum payment equal to the executive’s annual incentive award for the fiscal year in which the termination occurred;
|
|
•
|
a lump sum payment equal to 18 multiplied by the COBRA premium in effect for the type of medical, dental, and vision coverage then in effect for Mr. Lowe;
|
|
•
|
reimbursement for the additional costs of continuing the executive’s group medical, dental and vision coverage under COBRA for 12 months or until he is eligible for new healthcare coverage, whichever is shorter;
|
|
•
|
continued vesting of RSUs and options granted to Mr. Lowe under the LTIP that are subject to time-based vesting requirements only during the 18 months following the date of employment termination as if Mr. Lowe’s employment had not terminated, and continued vesting during the 18 months following the date of termination of PSUs in accordance with the terms of such awards as if Mr. Lowe’s employment had not terminated, although PSUs that may vest will be paid out based upon actual Company performance in accordance with the terms of the LTIP and the applicable award agreement, including prorating for the portion of time Mr. Lowe provided services to the Company over the course of the applicable performance period and such additional 18-month period, as applicable; and
|
|
•
|
continued vesting of RSUs and options during the 12 months following the date of employment termination as if the executive’s employment had not terminated, and continued vesting of PSUs during the 12 months following the date of termination in accordance with the terms of such awards as if the executive’s employment had not terminated, although PSUs that may vest will be paid out based upon actual Company performance in accordance with the terms of the LTIP and the applicable award agreement, including prorating for the portion of time the executive provided services to the Company over the course of the applicable performance period and such additional 12-month period, as applicable; and
|
|
•
|
in the event that Mr. Lowe’s employment is terminated on or before October 31, 2019, reimbursement by the Company for any loss incurred in the sale of Mr. Lowe’s primary North Carolina residence.
|
|
•
|
outplacement benefits for 12 months.
|
|
Change in Control Agreement (Mr. Lowe):
|
|
SLT Severance Plan:
|
||
|
•
|
Mr. Lowe’s willful and continued failure to substantially perform the reasonable and lawful duties and responsibilities of his position that is not corrected after one written warning detailing the concerns and offering Mr. Lowe a reasonable period of time to cure;
|
|
•
|
an executive’s willful and continued failure to substantially perform the reasonable and lawful duties and responsibilities of the executive’s position that is not corrected after one written warning detailing the concerns and offering him a reasonable period of time to cure;
|
|
•
|
any material and willful violation of any federal or state law by Mr. Lowe in connection with his responsibilities as an employee of the Company;
|
|
•
|
any material and willful failure of an executive to comply with Company policies (including but not limited to the Company’s Code of Conduct), applicable government laws, rules and regulations and/or reasonable directives of the CEO or Board of Directors;
|
|
•
|
any act of personal dishonesty taken by Mr. Lowe in connection with his responsibilities as an employee of the Company with the intention or reasonable expectation that such may result in his personal enrichment;
|
|
•
|
any dishonest or illegal action (including, without limitation, embezzlement) or any other action whether or not dishonest or illegal by an executive which is materially detrimental to the interest and well-being of the Company, including, without limitation, harm to its reputation;
|
|
•
|
Mr. Lowe’s conviction of, or plea of nolo contendere to, or grant of prayer of judgment continued with respect to, a felony that the Board of Directors reasonably believes has had or will have a material detrimental effect on the Company’s reputation or business; or
|
|
•
|
an executive’s conviction of, or plea of nolo contendere to, or grant of prayer of judgment continued with respect to, a felony that the Board of Directors reasonably believes has had or will have a material detrimental effect on the Company’s reputation or business;
|
|
•
|
Mr. Lowe materially breaching his Confidential Information Agreement, which breach is not cured.
|
|
•
|
an executive’s material breach of his Confidential Information Agreement.
|
|
Change in Control Agreement (Mr. Lowe):
|
|
SLT Severance Plan:
|
||
|
|
|
|
•
|
an executive’s failure to fully disclose any material conflict of interest that he may have with the Company in a transaction between the Company and any third party which is materially detrimental to the interest and well-being of the Company; or
|
|
|
|
|
•
|
an executive’s commission of any act or omission that has caused or could cause material reputational damage to the Company.
|
|
Change in Control Agreement (Mr. Lowe):
|
|
SLT Severance Plan:
|
||
|
•
|
a material reduction in Mr. Lowe’s authority, duties or responsibilities, including removal from, or a failure to elect Mr. Lowe to, the Board of Directors;
|
|
•
|
a material reduction in the executive’s authority, duties or responsibilities, provided however, that this will not apply to the sale, transfer or other disposition of all or substantially all of the stock or assets of a business unit for which the applicable executive was not the primary executive responsible;
|
|
•
|
a material reduction in Mr. Lowe’s base salary or target annual and long-term incentive compensation, other than a one-time reduction in either case that also is applied to substantially all other executive officers of the Company, provided that Mr. Lowe’s reduction is substantially proportionate to the reduction applied to substantially all other executive officers;
|
|
•
|
a material reduction in the executive’s annual base salary, target annual compensation (bonus), or long-term incentive compensation (including, but not limited to equity compensation);
|
|
•
|
the Company requiring Mr. Lowe to report to anyone other than the Board of Directors; or
|
|
•
|
the Company requiring the executive to report to anyone other than the CEO of Cree; or
|
|
•
|
the Company requiring Mr. Lowe to relocate his principal place of business or the Company relocating its headquarters, in either case to a facility or location outside of a 35 mile radius (or such longer distance that is the minimum permissible distance under the circumstances for purposes of the involuntary separation from service standards under the Treasury Regulations or other guidance under Section 409A of the Code) from Mr. Lowe’s current principal place of employment.
|
|
•
|
the Company requiring the executive to relocate his principal place of business or the Company relocating its headquarters, in either case to a facility or location outside of a 35 mile radius from his current principal place of employment.
|
|
•
|
any person or group of persons becomes the beneficial owner of 50% or more of our outstanding common stock or the combined voting power of our securities entitled to vote generally in the election of directors;
|
|
•
|
a sale or other disposition of all or substantially all of our assets;
|
|
•
|
shareholder approval of a definitive agreement or plan to liquidate our company;
|
|
•
|
a merger or consolidation of our company with and into another entity, unless immediately following such transaction (1) more than 50% of the members of the governing body of the surviving entity were incumbent directors at the time of execution of the initial agreement providing for such transaction; (2) no person or group of persons is the beneficial owner, directly or indirectly, of 50% or more of the equity interests of the surviving entity or the combined voting power of the equity interests of the surviving entity entitled to vote generally in the election of members of its governing body; and (3) more than 50% of the equity interests of the surviving entity and the combined voting power of the equity interests of the surviving entity entitled to vote generally in the election of members of its governing body is beneficially owned, directly or indirectly, by all or substantially all of the individuals and entities who were the beneficial owners of the shares of common stock immediately prior to such transaction in substantially the same proportions as their ownership immediately prior to such transaction;
|
|
•
|
A change in the majority of the incumbent directors of the Board of Directors during a consecutive 24-month period during the executive’s employment term, excluding such changes resulting from directors who are elected by, or on the recommendation of or with the approval of, at least two-thirds of the directors qualifying as incumbent directors; or
|
|
•
|
in the case of the SLT Severance Plan, the sale, transfer or other disposition of all or substantially all of the stock or assets of a business unit of Cree or a similar transaction as the Board of Directors, in its sole discretion, may determine to be a “change in control”; provided, however, that “change in control” will not include (1) a transaction the sole purpose of which is to change the state of our incorporation; or (2) the initial public offering of the stock of a Business Unit of our company, and any subsequent sell down of the stock of the Business Unit by our company.
|
|
•
|
within the period of time between the commencement of a tender offer or our entry into a written agreement with another party that contemplates a transaction, the consummation of either of which would result in a change in control and the occurrence of either the resulting change in control or the termination or expiration of the tender offer or the written agreement without the occurrence of a change in control; or
|
|
•
|
within 24 months following a change in control.
|
|
•
|
$455,000, which amount is equal to Mr. McDevitt’s base salary to be paid in equal monthly installments over the 12 months following the separation date;
|
|
•
|
$364,000, which amount is equal to Mr. McDevitt’s annual targeted bonus opportunity at target for fiscal 2019;
|
|
•
|
reimbursement for the additional costs of continuing Mr. McDevitt’s Company-sponsored group medical, dental, and vision coverage under COBRA applicable to the type of medical, dental, and vision coverage in effect for Mr. McDevitt as of the separation date for the 12-month period following the separation date, or until he is eligible for new group healthcare coverage, whichever is shorter;
|
|
•
|
outplacement benefits for a 12-month period; and
|
|
•
|
conditioned on Mr. McDevitt’s fulfillment of his obligations for consulting, continued compliance with all other terms of the McDevitt Separation Agreement through each applicable vesting date, and upon execution and delivery of a supplemental release, (i) any RSUs granted to Mr. McDevitt under the
|
|
Name
|
|
Triggering Event
|
|
Type of Payment/Benefit
|
|
Amount
|
||
|
Gregg A. Lowe
|
|
Death or termination of employment due to
|
|
Annual incentive award (1)
|
|
$
|
1,241,051
|
|
|
|
|
long-term disability
|
|
Vesting acceleration (2)
|
|
38,185,349
|
|
|
|
|
|
|
|
|
|
$
|
39,426,400
|
|
|
|
|
Change in control (not involving
|
|
Annual incentive award (4)
|
|
$
|
1,241,051
|
|
|
|
|
termination of employment) (3)
|
|
|
|
$
|
1,241,051
|
|
|
|
|
Termination without cause or resignation
|
|
Base salary (18 months)
|
|
$
|
1,275,000
|
|
|
|
|
for good reason not in connection with a
|
|
Incentive awards
|
|
1,785,000
|
|
|
|
|
|
change in control (5)
|
|
COBRA premiums (18 months)
|
|
31,353
|
|
|
|
|
|
|
|
Continued vesting (18 months)
|
|
25,116,758
|
|
|
|
|
|
|
|
|
|
$
|
28,208,111
|
|
|
|
|
Termination without cause or resignation
|
|
Base salary (24 months)
|
|
$
|
1,700,000
|
|
|
|
|
for good reason in connection with a
|
|
Incentive awards
|
|
2,380,000
|
|
|
|
|
|
change in control (5)
|
|
COBRA premiums (24 months)
|
|
41,804
|
|
|
|
|
|
|
|
Vesting acceleration
|
|
38,145,349
|
|
|
|
|
|
|
|
Outplacement services (12 months)
|
|
6,500
|
|
|
|
|
|
|
|
|
|
$
|
42,313,653
|
|
|
Neill P. Reynolds
|
|
Death or termination of employment due to
|
|
Annual incentive award (1)
|
|
$
|
379,616
|
|
|
|
|
long-term disability
|
|
Vesting acceleration (2)
|
|
4,144,174
|
|
|
|
|
|
|
|
|
|
$
|
4,523,790
|
|
|
|
|
Change in control (not involving
|
|
Annual incentive award (4)
|
|
$
|
379,616
|
|
|
|
|
termination of employment) (3)
|
|
|
|
$
|
379,616
|
|
|
|
|
Termination without cause or resignation
|
|
Base salary (12 months)
|
|
$
|
455,000
|
|
|
|
|
for good reason not in connection with a
|
|
Incentive awards
|
|
364,000
|
|
|
|
|
|
change in control (5)
|
|
COBRA premiums (12 months)
|
|
13,210
|
|
|
|
|
|
|
|
Outplacement services (12 months)
|
|
6,500
|
|
|
|
|
|
|
|
Continued vesting (12 months)
|
|
770,888
|
|
|
|
|
|
|
|
|
|
$
|
1,609,598
|
|
|
|
|
Termination without cause or resignation
|
|
Base salary (18 months)
|
|
$
|
682,500
|
|
|
|
|
for good reason in connection with a
|
|
Incentive awards
|
|
546,000
|
|
|
|
|
|
change in control (5)
|
|
COBRA premiums (18 months)
|
|
19,815
|
|
|
|
|
|
|
|
Vesting acceleration
|
|
4,144,174
|
|
|
|
|
|
|
|
Outplacement services (12 months)
|
|
6,500
|
|
|
|
|
|
|
|
|
|
$
|
5,398,989
|
|
|
Michael E. McDevitt
|
|
Compensation pursuant to the McDevitt
|
|
Base salary (12 months)
|
|
$
|
455,000
|
|
|
|
|
Separation Agreement (6)
|
|
Annual incentive award
|
|
364,000
|
|
|
|
|
|
|
|
COBRA Premiums (12 months)
|
|
18,487
|
|
|
|
|
|
|
|
Outplacement services (12 months)
|
|
6,500
|
|
|
|
|
|
|
|
Continued vesting (12 months)
|
|
3,297,696
|
|
|
|
|
|
|
|
|
|
$
|
4,141,683
|
|
|
David T. Emerson
|
|
Death or termination of employment due to
|
|
Annual incentive award (1)
|
|
—
|
|
|
|
|
|
long-term disability
|
|
Vesting acceleration (2)
|
|
$
|
5,218,041
|
|
|
|
|
|
|
|
|
$
|
5,218,041
|
|
|
|
|
Change in control (not involving
|
|
Annual incentive award (4)
|
|
—
|
|
|
|
|
|
termination of employment) (3)
|
|
|
|
—
|
|
|
|
|
|
Termination without cause or resignation
|
|
Base salary (12 months)
|
|
$
|
412,000
|
|
|
|
|
for good reason not in connection with a
|
|
Incentive awards (6)
|
|
329,600
|
|
|
|
|
|
change in control (7)
|
|
COBRA premiums (12 months)
|
|
13,048
|
|
|
|
|
|
|
|
Outplacement services (12 months)
|
|
6,500
|
|
|
|
|
|
|
|
Continued vesting (12 months)
|
|
2,588,999
|
|
|
|
|
|
|
|
|
|
$
|
3,350,147
|
|
|
Name
|
|
Triggering Event
|
|
Type of Payment/Benefit
|
|
Amount
|
||
|
|
|
Termination without cause or resignation
|
|
Base salary (18 months)
|
|
$
|
618,000
|
|
|
|
|
for good reason in connection with a
|
|
Annual incentive award
|
|
494,400
|
|
|
|
|
|
change in control (7)
|
|
COBRA premiums (18 months)
|
|
19,572
|
|
|
|
|
|
|
|
Vesting acceleration
|
|
5,218,041
|
|
|
|
|
|
|
|
Outplacement services (12 months)
|
|
6,500
|
|
|
|
|
|
|
|
|
|
$
|
6,356,513
|
|
|
(1)
|
Based on actual results for performance period using 104% performance measurement for the Cree-wide financial goals. Assumes no prior leave of absence in the case of death. In the case of termination due to long-term disability, assuming 180 days prior leave of absence, payment would have been $1,190,000 for Mr. Lowe and $364,000 for Mr. Reynolds. Actual amount will vary based on performance measurement and the duration of any leave of absence prior to death or termination due to long-term disability. Mr. Emerson was not eligible to receive an annual cash incentive compensation payment for fiscal 2019 because he was not continuously employed as an executive officer through the last day of the employment period for reasons other than death or termination of employment due to long-term disability.
|
|
(2)
|
Vesting is automatically accelerated for nonqualified stock options, RSUs, and PSUs in the event of death or upon the effective date of the determination of the executive officer’s long-term disability pursuant to the terms of the award agreements under the LTIPs, which terms apply equally to all participants. For PSUs, vesting is accelerated in full at the greater of target or actual performance measure on the date of death or on the effective date of the determination of the disability. However, the PSUs will not be settled until the vesting date (third anniversary of the grant date) and the number of shares that will be issued at that time in settlement of the PSUs will be calculated as described above.
|
|
(3)
|
Pursuant to the SLT Severance Plan, the performance conditions for any outstanding PSUs at the time of a change in control not involving a termination of employment shall be deemed to have been met and achieved at the greater of (a) the target level and (b) the actual performance level (with the date of the change in control being treated as the ending date for the measurement period and the effective stock price of the change in control being used for the calculation of RTSR). Such PSUs shall thereafter continue to time-vest in accordance with the terms of the award; provided, however, that any then remaining unvested PSUs shall immediately vest in full in the event of a termination without cause or resignation for good reason. Except as described above, no accelerated vesting will occur for equity awards under the LTIP in connection with a change in control not involving termination of employment
unless
the outstanding awards are not assumed by the successor in connection with a change in control, and the Compensation Committee, in its discretion, accelerates vesting of the outstanding but unvested awards. If awards were not assumed by the successor and the Compensation Committee exercised its discretion to the fullest extent possible and determined that 100% of the outstanding awards should be vested (in the case of PSUs, based on the actual performance as of the date of the change of control), the named executive officers would have received the following additional amounts: $38,185,349 for Mr. Lowe, $4,144,174 for Mr. Reynolds and $5,218,041 for Mr. Emerson.
|
|
(4)
|
The performance units granted to Messrs. Lowe and Reynolds provide that the performance measurement for determining his annual incentive award will be no less than 100% if a change in control occurs during the performance period. The amount in the table represents the additional amount each of Messrs. Lowe and Reynolds would have received as a result of this provision and excludes any amount he would otherwise be entitled to receive based on actual performance results. Mr. Emerson was not eligible to receive an annual cash incentive compensation payment for fiscal 2019 because he was not continuously employed as an executive officer through the last day of the employment period.
|
|
(5)
|
The triggering event, along with resulting benefits, is defined in the Change in Control Agreement. In addition, the Company would have been required to promptly reimburse Mr. Lowe for any loss incurred in the sale of his North Carolina residence following his separation in an amount equal to (1) the greater of (a) the fair market value of such residence as determined by the Company’s third party relocation service, or (b) the purchase price of such residence and the documented cost of any capital improvements made to the such residence made by Mr. Lowe, over (2) the net sale price received by him.
|
|
(6)
|
The amount reported includes benefits paid to Mr. McDevitt pursuant to the McDevitt Separation Agreement.
|
|
(7)
|
The triggering event, along with resulting benefits, is defined in the SLT Severance Plan.
|
|
•
|
Calculating the compensation based on the consistently applied measure of target annual compensation as described above of all of our employees except the CEO;
|
|
•
|
Determining the median employee from our employee population based on this consistently applied compensation measure; and
|
|
•
|
Identifying the ten employees whose target annual compensation was situated above and below this median and calculating total annual compensation for this subset of employees using the same methodology we use for our named executive officers as set forth in the fiscal 2018 Summary Compensation Table in this proxy statement in accordance with Item 402 of Regulation S-K (the “Item 402 Rules”), excluding any employee who had anomalous compensation characteristics, to ensure that our selected median employee reflects our population as a whole and support the reasonableness of our consistently applied compensation measure.
|
|
•
|
There were options to purchase 1,950,329 shares of our common stock outstanding under all of our equity compensation plans, including legacy plans under which we will make no more grants. The weighted average remaining life of these outstanding options was 2.35 years, and the weighted average exercise price was $40.08.
|
|
•
|
There were 3,024,077 shares subject to outstanding stock awards that remain subject to forfeiture.
|
|
•
|
There were 5,525,575 shares available for future grants under the LTIP, 1,384,471 shares available for future issuance under the 2005 Employee Stock Purchase Plan, or ESPP, and 50,967 shares available for future issuance under the Non-Employee Director Stock Compensation and Deferral Program, or the Deferral Program.
|
|
Plan Category
|
|
(a)
Number of securities to be
issued upon exercise of
outstanding options,
warrants and rights (1)
|
|
(b)
Weighted average
exercise price of
outstanding options,
warrants and rights (2)
|
|
(c)
Number of securities
remaining available for
future issuance under
equity compensation plans
(excluding securities
reflected in column (a)) (1)
|
||||||
|
Equity compensation plans approved by security holders
|
|
5,498,224
|
|
(3)
|
|
$
|
39.81
|
|
|
7,450,360
|
|
(4)
|
|
Equity compensation plans not approved by security holders
|
|
48,192
|
|
(5)
|
|
—
|
|
|
51,808
|
|
(6)
|
|
|
Total
|
|
5,546,416
|
|
|
|
$
|
39.81
|
|
|
7,502,168
|
|
|
|
(1)
|
Refers to shares of the Company’s common stock.
|
|
(2)
|
The weighted average exercise price relates solely to outstanding stock option shares because shares subject to restricted stock units have no exercise price.
|
|
(3)
|
Includes shares issuable upon exercise of outstanding options and restricted stock units under the 2004 LTIP - 752,863 shares; and LTIP - 4,745,361 shares.
|
|
(4)
|
Includes shares remaining for future issuance under the following plans in the amounts indicated: LTIP - 6,065,889 shares and ESPP - 1,384,471 shares.
|
|
(5)
|
Includes deferred shares issued under the Deferral Program - 48,192 shares.
|
|
(6)
|
Includes shares remaining for future issuance under the Deferral Program.
|
|
Name
|
|
Fees Earned
or Paid
in Cash ($)
|
|
Stock Awards
($) (1)
|
|
Total ($)
|
||||||
|
John C. Hodge (2)
|
|
$
|
40,000
|
|
|
$
|
166,531
|
|
|
$
|
206,531
|
|
|
Clyde R. Hosein (3)
|
|
$
|
87,500
|
|
|
$
|
171,560
|
|
|
$
|
259,060
|
|
|
Robert A. Ingram (4)
|
|
$
|
60,000
|
|
|
—
|
|
|
$
|
60,000
|
|
|
|
Darren R. Jackson (5)
|
|
$
|
107,500
|
|
|
$
|
171,560
|
|
|
$
|
279,060
|
|
|
Duy-Loan T. Le (6)
|
|
$
|
37,500
|
|
|
$
|
166,531
|
|
|
$
|
204,031
|
|
|
C. Howard Nye (7)
|
|
$
|
40,000
|
|
|
—
|
|
|
$
|
40,000
|
|
|
|
John B. Replogle (8)
|
|
$
|
82,500
|
|
|
$
|
171,560
|
|
|
$
|
254,060
|
|
|
Thomas H. Werner (9)
|
|
$
|
85,000
|
|
|
$
|
171,560
|
|
|
$
|
256,560
|
|
|
Anne C. Whitaker (10)
|
|
$
|
75,000
|
|
|
$
|
171,560
|
|
|
$
|
246,560
|
|
|
(1)
|
Amounts listed in the Stock Awards column represent the aggregate grant date fair value of awards granted during fiscal 2019 calculated in accordance with ASC Topic 718. With respect to Messrs. Hosein, Jackson, Replogle, Werner and Ms. Whitaker, these amounts relate to the annual grant of 3,566 RSUs on September 1, 2018. With respect to Mr. Hodge and Ms. Le, these amounts relate to the annual grant of 4,442 RSUs on October 22, 2018. All awards were made under the LTIP. For a discussion of the assumptions used to value these awards, see Note 14 to our Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2019.
|
|
(2)
|
As of June 30, 2019, Mr. Hodge held 4,442 RSUs of which 1,481 will vest on October 22, 2019. The remaining 2,961 RSUs will vest as to 1,481 RSUs on October 22, 2020 and as to 1,480 RSUs on October 22, 2021. Lastly, Mr. Hodge deferred all of the $40,000 of fees earned in fiscal 2019 into the Deferral Program (as described below).
|
|
(3)
|
As of June 30, 2019, Mr. Hosein had 4,000 options outstanding, all of which were exercisable. In addition, Mr. Hosein held 3,566 RSUs that vested on September 1, 2019.
|
|
(4)
|
Mr. Ingram deferred all of the $60,000 of fees earned in fiscal 2019 into the Deferral Program.
|
|
(5)
|
As of June 30, 2019, Mr. Jackson held 3,566 RSUs that vested on September 1, 2019.
|
|
(6)
|
As of June 30, 2019, Mrs. Le held 4,442 RSUs of which 1,481 will vest on October 22, 2019. The remaining 2,961 RSU will vest as to 1,481 RSUs on October 22, 2020 and will vest as to 1,480 RSUs on October 22, 2021.
|
|
(7)
|
Mr. Nye deferred all of the $40,000 of fees earned in fiscal 2019 into the Deferral Program.
|
|
(8)
|
As of June 30, 2019, Mr. Replogle had 4,000 options outstanding, all of which were exercisable. In addition, Mr. Replogle held 4,442 RSUs that vested on September 1, 2019. Lastly, Mr. Replogle deferred all of the $82,500 of fees earned in fiscal 2019 into the Deferral Program.
|
|
(9)
|
As of June 30, 2019, Mr. Werner had 8,000 options outstanding, all of which were exercisable. In addition, Mr. Werner held 4,442 RSUs that vested on September 1, 2019.
|
|
(10)
|
As of June 30, 2019, Ms. Whitaker had 4,000 options outstanding, all of which were exercisable. In addition, Ms. Whitaker held 4,442 RSUs of which all vested on September 1, 2019.
|
|
|
Fiscal 2019
|
|
Fiscal 2018
|
||||
|
Audit Fees
|
$
|
3,339,000
|
|
|
$
|
3,032,000
|
|
|
Audit-Related Fees
|
65,000
|
|
|
50,000
|
|
||
|
Tax Fees
|
111,000
|
|
|
170,000
|
|
||
|
All Other Fees
|
3,000
|
|
|
3,000
|
|
||
|
Total
|
$
|
3,518,000
|
|
|
$
|
3,255,000
|
|
|
•
|
Aggressive financial targets for performance-based short-term cash incentive compensation
. The Committee established challenging annual Cree-wide financial targets for the fiscal 2019 performance-based cash incentive programs that applied to all of Cree’s named executive officers serving for the full fiscal year.
The targeted payout for Messrs. Lowe and Reynolds were based solely on Cree-wide revenue and non-GAAP gross margin targets. Cree achieved the Cree-wide threshold non-GAAP gross margin target (as adjusted by the Committee to reflect the divestment of the Lighting Products business unit), and therefore Messrs. Lowe and Reynolds were entitled to receive a payout of annual cash incentive compensation under the LTIP as described in “Results and Actual Payouts for Fiscal 2019” in the Compensation Discussion & Analysis section above. The Committee also awarded discretionary cash bonuses to Messrs. Lowe and Reynolds to reflect their contribution to Cree’s outstanding operational and strategic performance in fiscal 2019.
|
|
•
|
Proportion of performance-based pay
. Based on the Committee’s pay for performance philosophy, as a direct result of the Committee’s compensation decisions, approximately 77% of Mr. Reynolds’s target total direct compensation for fiscal 2019 was comprised of variable performance-based pay in the form of short-term cash incentives and long-term equity awards. Similarly, 91% of Mr. Lowe’s target total direct compensation for fiscal 2019 was comprised of these components.
|
|
•
|
Long-term equity compensation
. For fiscal 2019, Cree granted equity awards to Mr. Lowe and the named executive officers who served for the full fiscal year in the form of RSUs and PSUs to align the interests of the named executive officers with Cree shareholders and to facilitate named executive officer retention. None of the tranches of PSUs held by Mr. Lowe or Mr. Reynolds reached the three-year cliff vesting threshold in fiscal 2019, and accordingly none of their PSUs vested or became potentially payable in fiscal 2019.
|
|
•
|
Solicitation of shareholder feedback and revisions to compensation programs
. As discussed on page 28, the Company continued to actively engage in dialogue with shareholders during fiscal 2019, and has made changes to its compensation programs in years past based on such dialogue.
|
|
1
|
|
|
AKAMAI TECHNOLOGIES
|
|
34
|
|
|
LITTELFUSE
|
|
2
|
|
|
ALLSCRIPTS
|
|
35
|
|
|
LOGITECH
|
|
3
|
|
|
ARISTA NETWORKS
|
|
36
|
|
|
LUMENTUM
|
|
4
|
|
|
ATHENAHEALTH
|
|
37
|
|
|
MARVELL SEMICONDUCTOR
|
|
5
|
|
|
BENCHMARK ELECTRONICS
|
|
38
|
|
|
MAXIM INTEGRATED PRODUCTS
|
|
6
|
|
|
BLACKBERRY LIMITED
|
|
39
|
|
|
MICROSEMI
|
|
7
|
|
|
BRUKER
|
|
40
|
|
|
MKS INSTRUMENTS
|
|
8
|
|
|
CADENCE DESIGN SYSTEMS
|
|
41
|
|
|
NATIONAL INSTRUMENTS
|
|
9
|
|
|
CDK GLOBAL
|
|
42
|
|
|
NETGEAR
|
|
10
|
|
|
CIRRUS LOGIC
|
|
43
|
|
|
NETSCOUT SYSTEMS
|
|
11
|
|
|
CRITEO
|
|
44
|
|
|
NUANCE COMMUNICATIONS
|
|
12
|
|
|
CUBIC CORPORATION
|
|
45
|
|
|
OPEN TEXT
|
|
13
|
|
|
CURTISS WRIGHT CORPORATION
|
|
46
|
|
|
PALO ALTO NETWORKS
|
|
14
|
|
|
CYPRESS SEMICONDUCTOR
|
|
47
|
|
|
PANDORA MEDIA
|
|
15
|
|
|
DIGITAL REALTY TRUST
|
|
48
|
|
|
PLEXUS
|
|
16
|
|
|
DOLBY LABORATORIES
|
|
49
|
|
|
PTC-PARAMETRIC TECHNOLOGY
|
|
17
|
|
|
EASTMAN KODAK COMPANY
|
|
50
|
|
|
RED HAT
|
|
18
|
|
|
ENDURANCE INTERNATIONAL GROUP
|
|
51
|
|
|
SCIENTIFIC GAMES CORPORATION
|
|
19
|
|
|
ENTEGRIS
|
|
52
|
|
|
SERVICENOW
|
|
20
|
|
|
ESTERLINE TECHNOLOGIES
|
|
53
|
|
|
SHUTTERFLY
|
|
21
|
|
|
F5 NETWORKS
|
|
54
|
|
|
SUNPOWER
|
|
22
|
|
|
FINISAR
|
|
55
|
|
|
SYNAPTICS
|
|
23
|
|
|
FLIR SYSTEMS
|
|
56
|
|
|
SYNOPSYS
|
|
24
|
|
|
FORTINET
|
|
57
|
|
|
TERADATA
|
|
25
|
|
|
FTD
|
|
58
|
|
|
TERADYNE
|
|
26
|
|
|
GARMIN
|
|
59
|
|
|
TRIMBLE NAVIGATION
|
|
27
|
|
|
GODADDY.COM
|
|
60
|
|
|
TRIPADVISOR
|
|
28
|
|
|
GOPRO
|
|
61
|
|
|
TTM TECHNOLOGIES
|
|
29
|
|
|
INTELSAT
|
|
62
|
|
|
VERINT SYSTEMS
|
|
30
|
|
|
IPG PHOTONICS
|
|
63
|
|
|
VERISIGN
|
|
31
|
|
|
ITRON
|
|
64
|
|
|
VIASAT
|
|
32
|
|
|
KEYSIGHT TECHNOLOGIES
|
|
65
|
|
|
WORKDAY
|
|
33
|
|
|
KLA-TENCOR
|
|
66
|
|
|
XILINX
|
|
|
CREE, INC.
4600 SILICON DRIVE
DURHAM, NC 2770
3
|
VOTE BY INTERNET -
www.proxyvote.com
Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 P.M. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.
ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS
If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years.
|
|
|
|
|
VOTE BY PHONE - 1-800-690-6903
Use any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you call and then follow the instructions.
VOTE BY MAIL
Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to CREE, INC. c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.
|
|
|
|
|
||
|
TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:
|
|||
|
|
E84441-P28239
|
KEEP THIS PORTION FOR YOUR RECORDS
|
|
|
DETACH AND RETURN THIS PORTION ONLY
|
|||
|
THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.
|
|||
|
CREE, INC.
The Board of Directors recommends that you vote FOR the following:
Vote on Directors
|
For
All
|
Withhold
All
|
For All
Except
|
|
|
|
||||||||||||||
|
To withhold authority to vote for any individual nominee(s), mark “For All Except” and write the number(s) of the nominee(s) on the line below.
|
|
|
|
|
||||||||||||||||
|
1. ELECTION OF DIRECTORS
Nominees:
01) John C. Hodge
02) Clyde R. Hosein
03) Darren R. Jackson
04) Duy-Loan T. Le
|
05) Gregg A. Lowe
06) John B. Replogle
07) Thomas H. Werner
08) Anne C. Whitaker
|
|
|
|
¨
|
¨
|
¨
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
The Board of Directors recommends you vote FOR the following proposals.
Vote on Proposals
2. RATIFICATION OF THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING JUNE 28, 2020.
|
For
¨
|
Against
¨
|
Abstain
¨
|
|||||||||||||||||
|
3. ADVISORY (NONBINDING) VOTE TO APPROVE EXECUTIVE COMPENSATION.
|
¨
|
¨
|
¨
|
|||||||||||||||||
|
|
||||||||||||||||||||
|
|
|
|
|
|
||||||||||||||||
|
The shares represented by this proxy, when properly executed, will be voted in the manner directed herein by the undersigned Shareholder(s).
If no direction is made, this proxy will be voted FOR items 1, 2 and 3.
If any other matters properly come before the meeting or any adjournments thereof, the person named in this proxy will vote in their discretion, all as more specifically set forth in the Notice of Annual Meeting and Proxy Statement dated September 10, 2019, receipt of which is hereby acknowledged.
|
|
|
|
|
|
|
||||||||||||||
|
For address changes, please check this box and write the changes on the back where indicated.
|
|
|
¨
|
|
|
|||||||||||||||
|
Please indicate if you plan to attend this meeting.
|
|
¨
|
¨
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
Yes
|
No
|
|
|
|
|
|
|
|
|
||||||||
|
Please sign your name exactly as it appears on this proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.
|
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Signature [PLEASE SIGN WITHIN BOX]
|
Date
|
|
|
|
|
Signature (Joint Owners)
|
Date
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
E84442-P28239
|
||
|
|
|
|
|||||
|
|
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
|
|
|||||
|
|
CREE, INC.
ANNUAL MEETING OF SHAREHOLDERS
OCTOBER 28, 2019
|
|
|||||
|
|
The undersigned hereby appoints Gregg A. Lowe and Bradley D. Kohn, and each of them individually, as proxies and attorneys-in-fact of the undersigned, with full power of substitution, to represent the undersigned and to vote, in accordance with the directions in this proxy, all of the shares of stock of Cree, Inc. that the undersigned is entitled to vote at the 2019 Annual Meeting of Shareholders of Cree, Inc. to be held at the offices of the corporation in Customer Center 6, 4408 Silicon Drive, Durham, North Carolina 27703, on Monday, October 28, 2019 at 12:00 p.m. local time, and any and all adjournments thereof.
|
|
|||||
|
|
THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED AS DIRECTED BY THE SHAREHOLDER. IF NO SUCH DIRECTIONS ARE MADE, THIS PROXY WILL BE VOTED FOR THE ELECTION OF THE NOMINEES LISTED ON THE REVERSE SIDE FOR THE BOARD OF DIRECTORS AND FOR EACH PROPOSAL.
|
|
|||||
|
|
PLEASE MARK, SIGN, DATE AND RETURN THIS PROXY CARD PROMPTLY USING THE ENCLOSED REPLY ENVELOPE
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Address Changes
:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(If you noted any Address Changes above, please mark corresponding box on the reverse side.)
|
|
|
|
|
|
|
|
|
CONTINUED AND TO BE SIGNED ON REVERSE SIDE
|
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|